Clinical Trials Directory

Trials / Conditions / Appendiceal Cancer

Appendiceal Cancer

13 registered clinical trials studyying Appendiceal Cancer — 6 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Feasibility Study of Mass-Based Response Drug Screening to Guide Personalized Hyperthermic Intraperitoneal C
NCT07291180
Yale UniversityN/A
RecruitingIntraoperative Imaging of Gastrointestinal Malignancies Using Pafolacianine (CYTALUX™)
NCT07124351
Cedars-Sinai Medical CenterPhase 4
RecruitingMolecular Characterisation of Appendiceal Cancer
NCT05364788
The Christie NHS Foundation Trust—
RecruitingLocally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG)
NCT06101277
University of California, DavisN/A
RecruitingGenetics of Appendix Cancer Study
NCT05734430
Andreana Holowatyj, PhD, MSCI—
Active Not RecruitingStudy of Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis From Colo
NCT05185947
National Cancer Institute (NCI)Phase 2
Active Not RecruitingJAB-21822 in Combination With Cetuximab in Patients With Advanced CRC and Other Solid Tumors With KRAS G12C Mu
NCT05194995
Allist Pharmaceuticals, Inc.Phase 1 / Phase 2
RecruitingIndividual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosi
NCT04847063
National Cancer Institute (NCI)Phase 1
TerminatedIntraperitoneal Oxaliplatin in Combo w IV mFOLFIRI for Peritoneal Carcinomatosis From Colorectal & Appendiceal
NCT04158349
University of UtahPhase 1
CompletedTrial of Cytoreductive Surgery and HIPEC in Patients With Primary and Secondary Peritoneal Cancers
NCT03604653
Holy Name Medical Center, Inc.—
CompletedA Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignanc
NCT02963831
Ludwig Institute for Cancer ResearchPhase 1 / Phase 2
CompletedHIPEC for Peritoneal Carcinomatosis
NCT02040142
Albert Einstein College of MedicinePhase 2
CompletedSurgical Outcome and Predictors of Overall Survival of Stage I-III Appendiceal Adenocarcinoma
NCT05452382
Mansoura University—